# Cytek Biosciences, Inc. (CTKB) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Cytek Biosciences, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/CTKB/mda/fy2025/): filed 2026-02-26; accession 0001628280-26-012352 (https://www.sec.gov/Archives/edgar/data/1831915/000162828026012352/ctkb-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/CTKB/mda/fy2024/): filed 2025-02-28; accession 0001628280-25-008780 (https://www.sec.gov/Archives/edgar/data/1831915/000162828025008780/ctkb-20241231.htm)
- [FY 2023 MD&A](/company/CTKB/mda/fy2023/): filed 2024-03-13; accession 0001628280-24-010933 (https://www.sec.gov/Archives/edgar/data/1831915/000162828024010933/ctkb-20231231.htm)
- [FY 2022 MD&A](/company/CTKB/mda/fy2022/): filed 2023-03-01; accession 0000950170-23-005610 (https://www.sec.gov/Archives/edgar/data/1831915/000095017023005610/ctkb-20221231.htm)
- [FY 2021 MD&A](/company/CTKB/mda/fy2021/): filed 2022-03-17; accession 0000950170-22-004106 (https://www.sec.gov/Archives/edgar/data/1831915/000095017022004106/ctkb-20211231.htm)

Back to /company/CTKB/